Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2020-09-30, filed 2020-11-16, with 17 holding rows worth $106,064,000.

Accession
0000919574-20-007059
Filed
2020-11-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2020

A holdings report, 17 entries on the cover page, a total value of $106,064,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $106,064,000 with VALUE read as thousands by filing date, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CARDIFF ONCOLOGY INC14147L108COM1,845,164$26,183,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM2,122,991$23,183,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD8,089,442$16,988,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CTI BIOPHARMA CORP12648L601COM4,313,617$9,274,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SIERRA ONCOLOGY INC82640U404CMN643,959$6,871,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
KALA BIO INC COM483119103Stock771,790$5,788,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SPDR GOLD TR78463V107GOLD SHS25,358$4,491,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
GARRISON CAP INC366554103COM1,164,061$4,447,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
SCYNEXIS INC811292200COM NEW834,370$3,680,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
PERSHING SQUARE TONTINE HLDG COM71531R109CL A67,369$1,529,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
IVERIC BIO INC46583P102COM192,738$1,087,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
EIGER BIOPHARMACEUTICALS INC28249U105COM112,872$919,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
CHURCHILL CAPITAL CORP IV171439201UNIT 99/99/999962,500$626,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
MEI PHARMA INC55279B202COM NEW175,560$548,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ADDEX THERAPEUTICS LTD00654J107SPONSORED ADS17,398$213,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
ESSA PHARMA INC29668H708COM NEW26,590$183,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.
Pershing Square T 25 WTS Warrants Exp 07/24/2571531R117WT7,485$54,000thousands by filing dateThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-20-007059this filing2020-11-16acceptance time not in the bulk data set